Related Experiment Video
Updated: Apr 3, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Stroke prevention in valvular heart disease: from the procedure to long-term management
Gennaro Giustino1, George D Dangas
1The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
Insights
Stroke is a rare but serious complication after transcatheter heart valve intervention in patients with valvular heart disease. Optimal antithrombotic strategies and cerebral embolic protection require further study to minimize stroke risks.
Area of Science:
- Cardiology
- Neurology
- Interventional Cardiology
Background:
- Stroke is a rare but severe complication in patients with valvular heart disease undergoing transcatheter interventions.
- Associated morbidity and mortality are significant, with risks influenced by valve disease type and procedure.
- Technical aspects of intra- and peri-procedural stroke have improved, yet post-intervention management remains uncertain.
Purpose of the Study:
- To review the current understanding of stroke in valvular heart disease patients undergoing transcatheter intervention.
- To identify uncertainties in post-intervention antithrombotic management and cerebral embolic protection.
- To highlight the need for further clinical studies to reduce stroke complications.
Main Methods:
- Literature review of studies on stroke in valvular heart disease patients.
- Analysis of technical factors influencing intra- and peri-procedural stroke.
- Discussion of antithrombotic strategies and cerebral embolic protection efficacy.
Main Results:
- Stroke is a recognized complication, though its incidence varies.
- Technical improvements have reduced procedural stroke, but optimal post-procedure management is unclear.
- The utility of routine cerebral embolic protection requires further investigation.
Conclusions:
- Further clinical research is essential to optimize antithrombotic management post-transcatheter intervention.
- Investigating the role of cerebral embolic protection is crucial.
- Minimizing stroke complications in this patient population requires continued study.
Abstract:
Stroke in patients with valvular heart disease undergoing transcatheter intervention is relatively rare but associated with significant morbidity and mortality. Risks vary according to the underlying valve disease and proposed procedure. While major improvements have been made in developing and understanding the technical factors associated with intra- and peri-procedural stroke, uncertainty exists regarding the optimal antithrombotic management strategy after transcatheter heart valve intervention and the utility of routine cerebral embolic protection. Further clinical studies are warranted to minimise these complications.
More Related Videos
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Mitral Stenosis III: Medical Management
Venous Thrombosis III: Interprofessional Care
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...

